Danny Benjamin, MD
Obstetrics & Gynecology · Commerce Twp, MINPI 1386699494
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,340 of the $6,299 with a category attached, or 68.9%. 41 manufacturers reported payments, led by Gynesonics, Inc. at 36.1% of the total. Reporting peaked in 2020 at $2,060 and has fallen 70.1% since, to $616 in 2025. Among obstetrics & gynecology clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 186 payments — averaging $33.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gynesonics, Inc.$2K
- Hologic Sales And Service, LLC$471
- Mayne Pharma Commercial LLC$389
- Fujirebio Diagnostics, Incorporated$350
- Myovant Sciences Inc.$347
- Sumitomo Pharma America, Inc.$326
- plus $2K from 35 others
What the payments were for
- Travel & lodging$1,48224%
- Food & beverage$4,34069%
- Education$4768%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,299 in reported general payments places this provider in the 90th percentile of 1,474 obstetrics & gynecology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 35 | $2,018 |
| Estradiol (Once Weekly)Estradiol | 19 | $1,939 |
| Estradiol (Twice Weekly)Estradiol | 12 | $1,668 |
| ProgesteroneProgesterone, Micronized | 14 | $809 |
| Lorazepam | 11 | $211 |
| Zolpidem Tartrate | 24 | $132 |
| Fluconazole | 27 | $127 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Commerce Twp
- David EisensteinDetroit$272K
- Peter TsengPort Huron$178K
- Robert ValiceChesterfield$175K
- Brent DavidsonDetroit$171K
- Michael EngelLake Orion$165K
- Ethan GoldsteinBloomfield Hills$140K
- Jay FisherWest Bloomfield$136K
- Barbara DepreeZeeland$118K
- Rabbie HannaDetroit$105K
- Gregory GresselGrand Rapids$85K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.